Nanoparticles Agents and Secondary Metabolites in Neurodegenerative Diseases

Name: Nanoparticles Agents and Secondary Metabolites in Neurodegenerative Diseases
Price: 432.96 AUD
Availability: OutOfStock
ISBN: 9798337313658

Jawad Laadraoui, Bilal El-Mansoury

$540.95 $432.96

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We will update you on expected arrival time to us. If this delay is too long, please let us know within 2 business days and we can give you options regarding cancelling or adjusting your order. More details on cancelling your order can be found in our Terms of Trade.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Igi Global Scientific Publishing
14 January 2026

Diseases & disorders; Neurology & clinical neurophysiology; Science: general issues; Nanotechnology

Neurodegenerative diseases, such as Alzheimer's, Parkinson's, and Huntington's, represent some of the most challenging and debilitating conditions affecting the aging population, with limited therapeutic options available. Recent advances in nanotechnology and natural product research open new avenues for intervention. The synergistic potential of engineered nanoparticles and bioactive secondary metabolites, such as flavonoids and terpenoids, crosses biological barriers and modulates oxidative stress and inflammation. This emerging interdisciplinary approach offers promising strategies for medical diagnosis, drug delivery, and disease modification in the fight against neurodegeneration. Nanoparticles Agents and Secondary Metabolites in Neurodegenerative Diseases explores two emerging therapeutic strategies in the treatment of neurodegenerative diseases. It examines the synergistic potential of nanoparticles and secondary metabolites. Covering topics such as neurodegenerative disease, metabolites, and nanoparticles, this book is an excellent resource for academicians, medical and healthcare professionals, engineers, and scientists.

Edited by: Jawad Laadraoui, Bilal El-Mansoury
Imprint: Igi Global Scientific Publishing
Dimensions: Height: 254mm, Width: 178mm, Spine: 29mm
Weight: 1.116kg
ISBN: 9798337313658
Pages: 410
Publication Date: 14 January 2026
Audience: General/trade , ELT Advanced
Format: Hardback
Publisher's Status: Active

Bilal El-Mansoury is a researcher in Neuroscience. His research focuses mainly on glial cells dysfunction in Hepatic encephalopathy and neurodegenerative disorders.